[JustaDumbBlonde]

I find it curious the company that developed zolpidem doesn't want to be involved in the testing on brain damaged patients. You would think that they would be shouting this from the rooftops (even though the drug is now available as a generic). Strange ...

[Old_Mil]

I find it curious the company that developed zolpidem doesn't want to be involved in the testing on brain damaged patients.

There are a lot of things that do or do not happen in the world of medicine and pharmaceuticals because of the chill effect of trial lawyers on the field, this may be one of them. Again, no guarantees, but it certainly is worth investigating.

[sig226]

The Guardian is often full of crap. I searched Yahoo for the drug name and I didn't see anything about this, although I only looked at a couple of pages because it is late.

I'll keep this thread up on my computer because I also want to look at it some more. Unfortunately it summons the cynic in me. One piece on it did mention that overdose might result in 'paradoxical insmonia.' It bears a further look.

[the Real fifi]

I believe the story says the patent has run out and generics are available. Trials are vey time consuming and expensive and if you no longer have the patent on the drug, you probably wouldn't bother either.

[wouldntbprudent]

YOu figured that out: the drug is now available as a genetic.

So the pharma company is desperately working on a slight chemical variation for use in these patients that they can repatent and make gazillions on.

Now that there's anything wrong with that.